Li Cong - Net Worth and Insider Trading
Li Cong Net Worth
The estimated net worth of Li Cong is at least $17 Million dollars as of 2024-06-22. Li Cong is the Director of Tonghua Dongbao Pharmaceutical Co Ltd and owns about 1,939,860 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) stock worth over $17 Million. Details can be seen in Li Cong's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Li Cong has not made any transactions after 2019-12-31 and currently still holds the listed stock(s).
Transaction Summary of Li Cong
Li Cong Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Li Cong owns 1 companies in total, including Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) .
Click here to see the complete history of Li Cong’s form 4 insider trades.
Insider Ownership Summary of Li Cong
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600867 | Tonghua Dongbao Pharmaceutical Co Ltd | 2019-12-31 | Director |
Li Cong Latest Holdings Summary
Li Cong currently owns a total of 1 stock. Li Cong owns 1,939,860 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) as of December 31, 2019, with a value of $17 Million.
Latest Holdings of Li Cong
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600867 | Tonghua Dongbao Pharmaceutical Co Ltd | 2019-12-31 | 1,939,860 | 8.85 | 17,167,761 |
Holding Weightings of Li Cong
Li Cong Form 4 Trading Tracker
According to the SEC Form 4 filings, Li Cong has made a total of 4 transactions in Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Tonghua Dongbao Pharmaceutical Co Ltd is the sale of 27,464 shares on December 31, 2019, which brought Li Cong around $347,420.
Insider Trading History of Li Cong
- 1
Li Cong Trading Performance
GuruFocus tracks the stock performance after each of Li Cong's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Li Cong is 35.47%. GuruFocus also compares Li Cong's trading performance to market benchmark return within the same time period. The performance of stocks bought by Li Cong within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Li Cong's insider trading performs compared to the benchmark.
Performance of Li Cong
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.48 | | | | | |
| Relative Return to S&P 500(%) | 6.52 | | | | | |
Li Cong Ownership Network
Li Cong Owned Company Details
What does Tonghua Dongbao Pharmaceutical Co Ltd do?
Who are the key executives at Tonghua Dongbao Pharmaceutical Co Ltd?
Li Cong is the Director of Tonghua Dongbao Pharmaceutical Co Ltd. Other key executives at Tonghua Dongbao Pharmaceutical Co Ltd include Supervisors Cheng Jian Qiu , senior management Chen Hong , and Supervisors Wang Dian Duo .
Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tonghua Dongbao Pharmaceutical Co Ltd Insider Transactions
Li Cong Mailing Address
Above is the net worth, insider trading, and ownership report for Li Cong. Currently GuruFocus does not have mailing address information for Li Cong.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
